Fideuram Asset Management Ireland dac Buys Shares of 3,075 Cigna Group $CI

Fideuram Asset Management Ireland dac purchased a new stake in shares of Cigna Group (NYSE:CIFree Report) in the 4th quarter, HoldingsChannel reports. The institutional investor purchased 3,075 shares of the health services provider’s stock, valued at approximately $846,000.

Several other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its holdings in shares of Cigna Group by 1.6% during the 4th quarter. Vanguard Group Inc. now owns 26,173,577 shares of the health services provider’s stock valued at $7,203,754,000 after buying an additional 414,834 shares during the last quarter. Massachusetts Financial Services Co. MA lifted its holdings in shares of Cigna Group by 8.3% during the 4th quarter. Massachusetts Financial Services Co. MA now owns 11,805,083 shares of the health services provider’s stock valued at $3,249,113,000 after buying an additional 903,334 shares during the last quarter. Dodge & Cox lifted its holdings in shares of Cigna Group by 4.0% during the 3rd quarter. Dodge & Cox now owns 9,305,225 shares of the health services provider’s stock valued at $2,682,231,000 after buying an additional 354,615 shares during the last quarter. Sanders Capital LLC lifted its holdings in shares of Cigna Group by 0.5% during the 3rd quarter. Sanders Capital LLC now owns 7,828,168 shares of the health services provider’s stock valued at $2,256,469,000 after buying an additional 35,150 shares during the last quarter. Finally, Geode Capital Management LLC lifted its holdings in shares of Cigna Group by 0.8% during the 4th quarter. Geode Capital Management LLC now owns 6,051,370 shares of the health services provider’s stock valued at $1,658,055,000 after buying an additional 48,474 shares during the last quarter. 86.99% of the stock is currently owned by institutional investors and hedge funds.

Cigna Group Stock Down 2.5%

Shares of CI stock opened at $277.08 on Friday. The stock’s 50 day simple moving average is $278.32 and its 200 day simple moving average is $276.88. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.73 and a current ratio of 0.73. Cigna Group has a twelve month low of $239.51 and a twelve month high of $338.89. The company has a market capitalization of $73.30 billion, a price-to-earnings ratio of 11.75, a PEG ratio of 1.00 and a beta of 0.30.

Cigna Group (NYSE:CIGet Free Report) last issued its quarterly earnings data on Thursday, April 30th. The health services provider reported $7.79 earnings per share for the quarter, beating analysts’ consensus estimates of $7.60 by $0.19. Cigna Group had a return on equity of 19.75% and a net margin of 2.26%.The business had revenue of $68.52 billion for the quarter, compared to the consensus estimate of $66.29 billion. During the same period last year, the business earned $6.74 EPS. The firm’s revenue was up 4.6% compared to the same quarter last year. Cigna Group has set its FY 2026 guidance at 30.350- EPS. As a group, research analysts predict that Cigna Group will post 30.39 EPS for the current year.

Cigna Group Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 18th. Investors of record on Thursday, June 4th will be paid a $1.56 dividend. This represents a $6.24 dividend on an annualized basis and a dividend yield of 2.3%. The ex-dividend date of this dividend is Thursday, June 4th. Cigna Group’s dividend payout ratio (DPR) is presently 26.45%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently issued reports on the company. Robert W. Baird set a $337.00 price target on Cigna Group in a report on Friday, May 1st. Guggenheim lifted their price target on Cigna Group from $334.00 to $338.00 and gave the company a “buy” rating in a report on Monday, May 4th. Morgan Stanley lifted their price target on Cigna Group from $355.00 to $361.00 and gave the company an “overweight” rating in a report on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft lowered Cigna Group from a “buy” rating to a “hold” rating and reduced their price target for the company from $303.00 to $302.00 in a report on Wednesday, May 20th. Finally, Truist Financial lifted their price target on Cigna Group from $320.00 to $350.00 and gave the company a “buy” rating in a report on Tuesday, February 17th. One equities research analyst has rated the stock with a Strong Buy rating, fourteen have assigned a Buy rating and six have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average price target of $339.50.

Get Our Latest Stock Report on CI

Insider Activity at Cigna Group

In other Cigna Group news, insider Nicole S. Jones sold 2,307 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $666,515.37. Following the transaction, the insider directly owned 32,647 shares of the company’s stock, valued at $9,432,044.77. The trade was a 6.60% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, insider Everett Neville sold 1,719 shares of Cigna Group stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $288.91, for a total value of $496,636.29. Following the completion of the transaction, the insider directly owned 5,670 shares in the company, valued at approximately $1,638,119.70. This represents a 23.26% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. In the last ninety days, insiders have sold 205,904 shares of company stock valued at $60,277,068. Corporate insiders own 0.60% of the company’s stock.

About Cigna Group

(Free Report)

Cigna Group (NYSE: CI) is a global health services company that offers a broad portfolio of healthcare products and insurance solutions for individuals, employers, and governments. Its core businesses include medical and behavioral health plans, dental and vision coverage, pharmacy benefit management, and supplemental health products. Cigna serves a mix of commercial, Medicare, and Medicaid customers and provides workplace benefits such as group health plans and disability and life benefits for employers.

In addition to traditional insurance products, Cigna operates health services and care-delivery platforms designed to manage costs and improve outcomes.

Recommended Stories

Want to see what other hedge funds are holding CI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CIFree Report).

Institutional Ownership by Quarter for Cigna Group (NYSE:CI)

Receive News & Ratings for Cigna Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cigna Group and related companies with MarketBeat.com's FREE daily email newsletter.